CXCL12 and head and neck cancer: A study by Jungbauer et al. further evaluated the role of CXCL12 on HPV+ and HPV− head and neck cancer cell lines and found that only HPV− cells lines showed increased podia formation in response to CXCL12 (Jungbauer et al., 2017).